Abstract
Advances in the treatment of Ewing's sarcoma have been dramatic. Present treatment protocols control local disease by radiotherapy, surgery, or both; systemic spread is limited by aggressive multiagent chemotherapy. In patients with localized osseous Ewing's sarcoma, five-year survival rates now range from 54% to an estimated 74%. With late relapse not uncommon, control of the primary lesion is critical to long-term survival. Several studies now show improved local control and possibly improved survival of patients with surgical treatment of primary osseous Ewing's sarcoma.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 78-87 |
| Number of pages | 10 |
| Journal | Clinical orthopaedics and related research |
| Issue number | 262 |
| State | Published - Jan 1 1991 |
ASJC Scopus subject areas
- Surgery
- Orthopedics and Sports Medicine